CRISPR Therapeutics AG (LTS:0VRQ) Days Sales Outstanding : 0.00 (As of Mar. 2024)

View and export this data going back to 2018. Start your Free Trial

What is CRISPR Therapeutics AG Days Sales Outstanding?

CRISPR Therapeutics AG's average Accounts Receivable for the three months ended in Mar. 2024 was $200.0 Mil. CRISPR Therapeutics AG's Revenue for the three months ended in Mar. 2024 was $0.0 Mil.

The historical rank and industry rank for CRISPR Therapeutics AG's Days Sales Outstanding or its related term are showing as below:

LTS:0VRQ' s Days Sales Outstanding Range Over the Past 10 Years
Min: 0.09 Med: 123.55 Max: 500.95
Current: 182.5

During the past 10 years, CRISPR Therapeutics AG's highest Days Sales Outstanding was 500.95. The lowest was 0.09. And the median was 123.55.

LTS:0VRQ's Days Sales Outstanding is ranked worse than
81.56% of 895 companies
in the Biotechnology industry
Industry Median: 72.67 vs LTS:0VRQ: 182.50

CRISPR Therapeutics AG's Days Sales Outstanding stayed the same from Mar. 2023 (0.00) to Mar. 2024 (0.00).

CRISPR Therapeutics AG Days Sales Outstanding Historical Data

The historical data trend for CRISPR Therapeutics AG's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CRISPR Therapeutics AG Days Sales Outstanding Chart

CRISPR Therapeutics AG Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

Get a 7-Day Free Trial

0.12

81.67

0.09

255.33

197.30

CRISPR Therapeutics AG Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Days Sales Outstanding	Get a 7-Day Free Trial															-	91.25	-	91.25	-

Competitive Comparison of CRISPR Therapeutics AG's Days Sales Outstanding

For the Biotechnology subindustry, CRISPR Therapeutics AG's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

CRISPR Therapeutics AG's Days Sales Outstanding Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, CRISPR Therapeutics AG's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where CRISPR Therapeutics AG's Days Sales Outstanding falls into.

CRISPR Therapeutics AG Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

CRISPR Therapeutics AG's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (0	+	200)	/	1 )	/	370	*	365
=	200					/	370	*	365
=	197.30

CRISPR Therapeutics AG's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

	Days Sales Outstanding (Q: Mar. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2023 )	+	Accounts Receivable (A: Mar. 2024 ))	/	count )	/	Revenue (A: Mar. 2024 )	*	Days in Period
=	( (200	+	0)	/	1 )	/	0	*	365 / 4
=	200					/	0	*	365 / 4
=	N/A

CRISPR Therapeutics AG (LTS:0VRQ) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

CRISPR Therapeutics AG Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of CRISPR Therapeutics AG's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

CRISPR Therapeutics AG (LTS:0VRQ) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CRISPR Therapeutics AG (LTS:0VRQ) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

CRSP:USA CRSP:Mexico

Address

Baarerstrasse 14, Zug, CHE, CH-6300

Website

https://www.crisprtx.com

CRISPR Therapeutics is a gene editing company focused on the development of CRISPR/Cas9-based therapeutics. CRISPR/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. The company is focused on using this technology to treat genetically defined diseases. CRISPR's most advanced pipeline candidate, exa-cel, is in collaboration with Vertex Pharmaceuticals and targets sickle cell disease and transfusion-dependent beta-thalassemia, which have high unmet medical needs. The company is progressing additional gene editing programs for immuno-oncology, as well as a stem cell-derived therapy for the treatment of Type 1 diabetes.

CRISPR Therapeutics AG (LTS:0VRQ) Headlines

No Headlines